Hypothesis: Circulating endothelial-derived exosomes enriched in senescence-associated miR-21 directly sensitize peripheral nociceptors via TLR7/8 signaling, lowering pain threshold and thus serving as a functional readout of vascular aging that predicts biological age more accurately than current epigenetic clocks.

Recent work shows that masters endurance athletes have superior vascular function and higher pain tolerance compared with sedentary peers 1. Accelerated epigenetic age correlates with heightened pain sensitivity in chronic pain conditions 2, while elite athletes exhibit both higher heat pain thresholds and favorable vascular phenotypes 3. Senescent endothelial cells secrete SASP factors that impair nitric oxide production and promote inflammation 4, and inflammatory mediators such as ICAM-1 overlap with pain pathways like the Substance P-NK1R system 5. Older adults also display reduced exercise-induced hypoalgesia 6 and age-related changes in descending pain modulation 7.

We propose that a specific SASP component—miR-21 loaded into endothelial exosomes—acts as a paracrine alarm signal. Exosomal miR-21 is taken up by dorsal root ganglion neurons, where it engages endosomal TLR7/8, triggering a MyD88‑dependent cascade that phosphorylates TRPV1 and lowers its activation threshold. This mechanism would translate endothelial senescence burden into heightened peripheral pain sensitivity without requiring central nervous system alterations.

Testable predictions: (1) Individuals with higher circulating endothelial exosome miR-21 levels will exhibit lower heat and mechanical pain thresholds, independent of traditional epigenetic age estimates. (2) Experimental neutralization of exosomal miR-21 (using antisense oligonucleotides or GW4869 to inhibit exosome release) in aged mice will normalize pain thresholds without altering DNA methylation age. (3) Conversely, infusion of purified miR-21‑rich endothelial exosomes into young mice will reduce pain tolerance and accelerate vascular senescence markers (e.g., increased ICAM-1, decreased eNOS coupling).

A prospective cohort of 200 adults spanning ages 20‑80 would undergo quantitative sensory testing, plasma isolation for endothelial exosome miR-21 quantification (via ELISA for CD31+/Annexin V+ particles and RT‑qPCR for miR-21), arterial stiffness measurement, and epigenetic age calculation (Horvath clock). Multiple regression would test whether exosomal miR-21 adds predictive power beyond epigenetic clocks for pain tolerance outcomes. Falsification would occur if exosomal miR-21 shows no association with pain thresholds after adjusting for vascular function and epigenetic age, or if manipulating exosomal miR-21 fails to shift pain sensitivity in animal models.

This hypothesis extends the observed link between pain tolerance and biological age by proposing a concrete, measurable mediator—endothelial exosomal miR-21—that integrates vascular senescence, inflammatory SASP, and nociceptor sensitization into a single testable pathway.